A team of researchers in Turkey have discovered multiple signs of stress in the eye after patients took Pfizer's COVID-19 ...

Moderna, already in cash-saving mode amid uncertain vaccine dynamics, is backing off from its plans to construct an mRNA drug ...

Moderna (MRNA) stock in focus as the company cancels plans for an mRNA manufacturing plant in Japan amid a challenging ...

The existence of “magnetic nanoparticles” in COVID mRNA vaccines has raised significant concerns among scientists and public health advocates alike. A recent study conducted by reputable researchers ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

IBM and Moderna released research on Thursday advancing the use of quantum computing in the development of mRNA medicines, a ...

I produced a video concerning the European Union which has the same nations in it as the Old Roman Empire. This is important because the Lord showed us in Daniel chapter 7 the beast that rose in ...

Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

This stock used to be a highflyer but has struggled in recent years as demand waned for its flagship product. Though Moderna ...